https://www.accessnewswire.com/newsroom/en/biotechnology/invitation-to-alligator-biosciences-earnings-call-on-12-february-2026-1133903
Invitation to Alligator Bioscience's Earnings Call on 12 February 2026
LUND, SE / ACCESS Newswire / February 5, 2026 / Alligator Bioscience (Nasdaq Stockholm:ATORX)(STO:ATORX), a clinical-stage biotechnology company developing...
alligator bioscienceearnings callinvitationfebruary
https://nordiclifescience.org/alligator-bioscience-gives-update-on-mitazalimab/
Alligator Bioscience gives update on mitazalimab - NLS
Apr 15, 2026 - In parallel with ongoing partnering activities, Alligator is exploring alternative opportunities for phase 3 development of mitazalimab.
alligator biosciencegivesupdatenls
https://www.prnewswire.co.uk/news-releases/alligator-bioscience-announces-immuno-oncology-research-collaboration-and-license-agreement-with-orion-corporation-820389393.html
Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with...
/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the company has entered into a research collaboration and license...
alligator bioscienceoncology researchlicense agreementannouncesimmuno
https://www.prnewswire.com/news-releases/alligator-bioscience-announces-completion-of-600-mg-dose-cohort-for-ator-1017-dose-escalation-and-enrollment-for-900-mg-dose-cohort-commences-301515562.html
Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and...
/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of the patient enrollment for the 600 mg dose cohort from...
alligator bioscienceannouncescompletionmgdose
https://www.distillintelligence.com/news/alligator-bioscience
Alligator Bioscience News: Latest Announcements
May 12, 2026 - Alligator Bioscience advanced its mitazalimab candidate toward Phase 3 trials and reported significantly improved financial results for Q1 2026.
alligator biosciencenews latestannouncements
https://markets.traderfox.com/aktien/83563541-alligator-bioscience-ab
Alligator Bioscience AB Aktie
Alligator Bioscience AB Aktie - aktueller Kurs, Echtzeit-Charts, Fundamentaldaten | SE0024173637 | A41BED
alligator bioscienceabaktie
https://biotechhunter.com/companies/alligator-bioscience
Alligator Bioscience | Biotech Hunter | Biotech Hunter
Antibody Therapeutics
alligator biosciencebiotechhunter
https://www.zonebourse.com/actualite-bourse/alligator-bioscience-fait-le-point-sur-le-mitazalimab-ce7e50d8d081f12c
Alligator Bioscience fait le point sur le mitazalimab | Zonebourse
Apr 10, 2026 - Alligator Bioscience fait le point sur le mitazalimab
alligator biosciencele pointfaitsurzonebourse